Long-term efficacy and safety of rituximab in the treatment of neuromyelitis Optica Spectrum disorder.
Michael T G HayesRobert J AdamPamela A McCombeMichael WalshStefan BlumPublished in: Multiple sclerosis journal - experimental, translational and clinical (2024)
Rituximab, at doses lower than traditionally used, may be an efficacious therapy for NMOSD, with a favourable safety profile.